Construction of a GLUT-1 and HIF-1α gene knockout cell model in HEp-2 cells using the CRISPR/Cas9 technique.

AKT CRISPR Cas9 system HEp-2 cells PI3K glucose transporter-1 hypoxia-inducible factor-1α laryngeal carcinoma mTOR pathway

Journal

Cancer management and research
ISSN: 1179-1322
Titre abrégé: Cancer Manag Res
Pays: New Zealand
ID NLM: 101512700

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 3 2019
pubmed: 19 3 2019
medline: 19 3 2019
Statut: epublish

Résumé

Glucose transporter (GLUT)-mediated glucose uptake is an important process in the development of laryngeal carcinoma, one of the most common malignancies of the head and neck. GLUT-1, together with HIF-1α, is also an indicator of hypoxia. Both proteins play a critical role in glucose uptake and glycolysis in laryngeal carcinoma cells under hypoxic stress. A double gene knockout model in which In this study we used the CRISPR/Cas 9 system to induce HIF-1α and GLUT-1 double gene knockout in HEp-2 cells and then used the knocked-out cells to study the role of these markers in laryngeal carcinoma, including in chemoradioresistance. High-grade small-guide RNAs (sgRNAs) of HIF-1α and GLUT-1 were designed using an online tool and inserted into the pUC57-T7-gRNA vector. The recombinant plasmids were transfected into HEp-2 cells and positive cells were screened using the dilution method. Gene mutation and expression were determined by sequence analysis and immunoblotting. In HIF-1α and GLUT-1 double gene knockout HEp-2 cells, a 171-bp deletion in the Our

Sections du résumé

BACKGROUND BACKGROUND
Glucose transporter (GLUT)-mediated glucose uptake is an important process in the development of laryngeal carcinoma, one of the most common malignancies of the head and neck. GLUT-1, together with HIF-1α, is also an indicator of hypoxia. Both proteins play a critical role in glucose uptake and glycolysis in laryngeal carcinoma cells under hypoxic stress. A double gene knockout model in which
PURPOSE OBJECTIVE
In this study we used the CRISPR/Cas 9 system to induce HIF-1α and GLUT-1 double gene knockout in HEp-2 cells and then used the knocked-out cells to study the role of these markers in laryngeal carcinoma, including in chemoradioresistance.
METHODS METHODS
High-grade small-guide RNAs (sgRNAs) of HIF-1α and GLUT-1 were designed using an online tool and inserted into the pUC57-T7-gRNA vector. The recombinant plasmids were transfected into HEp-2 cells and positive cells were screened using the dilution method. Gene mutation and expression were determined by sequence analysis and immunoblotting.
RESULTS RESULTS
In HIF-1α and GLUT-1 double gene knockout HEp-2 cells, a 171-bp deletion in the
CONCLUSION CONCLUSIONS
Our

Identifiants

pubmed: 30881132
doi: 10.2147/CMAR.S183859
pii: cmar-11-2087
pmc: PMC6413817
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2087-2096

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Oncol Rep. 2005 Oct;14(4):909-13
pubmed: 16142350
Dig Dis Sci. 2006 Dec;51(12):2198-205
pubmed: 17080242
BJU Int. 2008 Feb;101(4):480-4
pubmed: 17922867
Arch Gynecol Obstet. 2008 Jun;277(6):539-46
pubmed: 18026974
Oncol Rep. 2008 Jan;19(1):111-6
pubmed: 18097583
Pathology. 2009;41(3):254-60
pubmed: 19142800
Ann Diagn Pathol. 2010 Feb;14(1):23-9
pubmed: 20123453
J Int Med Res. 2010;38(6):1885-92
pubmed: 21226991
Cancer Res. 2011 Mar 1;71(5):1647-57
pubmed: 21239473
Histopathology. 2011 Jun;58(7):1136-47
pubmed: 21438910
Head Neck Oncol. 2012 May 02;4:18
pubmed: 22551172
Oncol Lett. 2013 Jan;5(1):261-266
pubmed: 23255932
Int J Med Sci. 2013 Aug 21;10(10):1375-86
pubmed: 23983599
Oncol Lett. 2014 Apr;7(4):984-990
pubmed: 24944654
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3938-47
pubmed: 25120770
Plant Cell Physiol. 2015 Jan;56(1):41-7
pubmed: 25392068
Oncol Lett. 2015 Feb;9(2):806-810
pubmed: 25621055
Gene Ther. 2015 Oct;22(10):822-9
pubmed: 26043872
Oncol Rep. 2015 Oct;34(4):1805-14
pubmed: 26238658
PLoS One. 2015 Nov 24;10(11):e0143306
pubmed: 26600164

Auteurs

Zhong-Jie Lu (ZJ)

Department of Radiotherapy.

Qi Yu (Q)

Department of Otolaryngology, 1190051@zju.edu.cn.

Shui-Hong Zhou (SH)

Department of Otolaryngology, 1190051@zju.edu.cn.

Jun Fan (J)

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.

Li-Fang Shen (LF)

Department of Otolaryngology, 1190051@zju.edu.cn.

Yang-Yang Bao (YY)

Department of Otolaryngology, 1190051@zju.edu.cn.

Ting-Ting Wu (TT)

Department of Otolaryngology, 1190051@zju.edu.cn.

Min-Li Zhou (ML)

Department of Otolaryngology, 1190051@zju.edu.cn.

Ya-Ping Huang (YP)

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.

Classifications MeSH